logo
Sign in

FNAM Stock Price, Chart, Stats & News

Evolutionary Genomics, Inc.
Save

Evolutionary Genomics, Inc. (FNAM) does not currently pay a dividend.

1,331
Market cap
Current P/E
Forward P/E

FNAM chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities.

Similar securities

Based on sector and market capitalization

Report issue